Magdalena Fay, MD MS (@magdafaymd) 's Twitter Profile
Magdalena Fay, MD MS

@magdafaymd

PGY1 @mghmedres | alum @CleClinicLCM + @UNCpublichealth | pursuing medical oncology

ID: 1793451500171059200

calendar_today23-05-2024 01:19:14

5 Tweet

37 Followers

81 Following

Zach Klaassen (@zklaassen_md) 's Twitter Profile Photo

Independent blinded validation of an AI-based digital histology classifier (PATHOMIQ_PRAD score) for BCR and mets risk prediction #ASCO24 Magdalena Fay, MD MS UroToday.com Cleveland Clinic Urology ⚡️n=263 RP (mF/U 50 mo) -> 65 BCR -> 14 distant mets ⚡️PATHOMIQ_PRAD score ⬆️ vs ⬇️: assoc with BCRFS

Independent blinded validation of an AI-based digital histology classifier (PATHOMIQ_PRAD score) for BCR and mets risk prediction #ASCO24 <a href="/MagdaFayMD/">Magdalena Fay, MD MS</a> <a href="/urotoday/">UroToday.com</a> <a href="/CleClinicUro/">Cleveland Clinic Urology</a> 

⚡️n=263 RP (mF/U 50 mo) -&gt; 65 BCR -&gt; 14 distant mets
⚡️PATHOMIQ_PRAD score ⬆️ vs ⬇️: assoc with BCRFS
UroToday.com (@urotoday) 's Twitter Profile Photo

Independent blinded validation of an AI-based digital histology classifier for #ProstateCancer recurrence and metastasis risk prediction. Presented by Magdalena Fay, MD MS. #ASCO24 written coverage by Zach Klaassen > bit.ly/3Vr6POe ASCO

Independent blinded validation of an AI-based digital histology classifier for #ProstateCancer recurrence and metastasis risk prediction. Presented by <a href="/MagdaFayMD/">Magdalena Fay, MD MS</a>. #ASCO24 written coverage by <a href="/zklaassen_md/">Zach Klaassen</a> &gt; bit.ly/3Vr6POe <a href="/ASCO/">ASCO</a>